Pharmacogenomic Information on Carglumic Acid

Pharmacogenomic Information

DrugTherapeutic Area*
Labeling Sections
Carglumic AcidInborn Errors of MetabolismNAGSN-acetylglutamate
synthase deficient
Indications and Usage,
Warnings and Precautions, Use in Specific Populations
Clinical Pharmacology
Clinical Studies


* Therapeutic areas do not necessarily reflect the CDER review division.

† Standard nomenclature is used for genes as per the Human Genome Organization symbol, cytogenetic abnormalities as per the International System for Human Cytogenetic Nomenclature, or other conventions.


back to Table of Pharmacogenomic Biomarkers in Drug Labeling

Page Last Updated: 02/22/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.